Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Seminars in Oncology
|
October 26, 2000
Rational development of capecitabine
C Twelves, A Anthoney
Methods in Molecular Medicine
|
March 5, 2011
Drug resistance : the clinical perspective
D A Anthoney, S B Kaye
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 4, 1999
Treatment for poor prognosis metastatic germ-cell tumours: much heat but, as yet, little light
D A Anthoney, S B Kaye
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice
|
August 14, 2002
DNA: still a target worth aiming at? A review of new DNA-interactive agents
D A Anthoney, C J Twelves
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 4, 2000
Inflammatory demyelinating polyneuropathy: a complication of immunotherapy in malignant melanoma
D A Anthoney, I Bone, T R Evans
The Journal of Biological Chemistry
|
August 16, 1996
Cisplatin and adriamycin resistance are associated with MutLalpha and mismatch repair deficiency in an ovarian tumor cell line
J T Drummond, A Anthoney, R Brown, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
December 24, 2005
Intravenous irinotecan plus oral ciclosporin
N S Vasudev, S Jagdev, D A Anthoney, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 1, 1995
Colonic adenocarcinoma associated ectopic ACTH secretion: a case history
D A Anthoney, D J Dunlop, J M Connell, et al.
Annals of Clinical Biochemistry
|
April 26, 2007
Monitoring the treatment of carcinoid disease using blood serotonin and plasma 5-hydroxyindoleacetic acid: three case examples
K R Allen, T J Degg, D A Anthoney, et al.
Cancer Research
|
March 15, 1996
Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells
D A Anthoney, A J McIlwrath, W M Gallagher, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Seminars in Oncology
|
October 26, 2000
Rational development of capecitabine
C Twelves, A Anthoney
Methods in Molecular Medicine
|
March 5, 2011
Drug resistance : the clinical perspective
D A Anthoney, S B Kaye
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 4, 1999
Treatment for poor prognosis metastatic germ-cell tumours: much heat but, as yet, little light
D A Anthoney, S B Kaye
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice
|
August 14, 2002
DNA: still a target worth aiming at? A review of new DNA-interactive agents
D A Anthoney, C J Twelves
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 4, 2000
Inflammatory demyelinating polyneuropathy: a complication of immunotherapy in malignant melanoma
D A Anthoney, I Bone, T R Evans
The Journal of Biological Chemistry
|
August 16, 1996
Cisplatin and adriamycin resistance are associated with MutLalpha and mismatch repair deficiency in an ovarian tumor cell line
J T Drummond, A Anthoney, R Brown, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
December 24, 2005
Intravenous irinotecan plus oral ciclosporin
N S Vasudev, S Jagdev, D A Anthoney, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 1, 1995
Colonic adenocarcinoma associated ectopic ACTH secretion: a case history
D A Anthoney, D J Dunlop, J M Connell, et al.
Annals of Clinical Biochemistry
|
April 26, 2007
Monitoring the treatment of carcinoid disease using blood serotonin and plasma 5-hydroxyindoleacetic acid: three case examples
K R Allen, T J Degg, D A Anthoney, et al.
Cancer Research
|
March 15, 1996
Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells
D A Anthoney, A J McIlwrath, W M Gallagher, et al.
Page
of 4